[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1050132A1 - 治療癌症的溶瘤配方 - Google Patents

治療癌症的溶瘤配方

Info

Publication number
HK1050132A1
HK1050132A1 HK03100750.7A HK03100750A HK1050132A1 HK 1050132 A1 HK1050132 A1 HK 1050132A1 HK 03100750 A HK03100750 A HK 03100750A HK 1050132 A1 HK1050132 A1 HK 1050132A1
Authority
HK
Hong Kong
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Application number
HK03100750.7A
Other languages
English (en)
Inventor
Herbert Fleisch Jerome
Stuart Benjamin Roger
Scott Sawyer Jason
Ann Teicher Beverly
Wade Beight Douglas
C R Smith Edward
Thomas Mcmillen William
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1050132A1 publication Critical patent/HK1050132A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HK03100750.7A 1999-11-11 2003-01-29 治療癌症的溶瘤配方 HK1050132A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
HK1050132A1 true HK1050132A1 (zh) 2003-06-13

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100750.7A HK1050132A1 (zh) 1999-11-11 2003-01-29 治療癌症的溶瘤配方

Country Status (22)

Country Link
EP (1) EP1231938A2 (zh)
JP (1) JP2003513916A (zh)
KR (1) KR20020069512A (zh)
CN (1) CN1390139A (zh)
AR (1) AR032432A1 (zh)
AU (1) AU778829B2 (zh)
BR (1) BR0015490A (zh)
CA (1) CA2391416A1 (zh)
CZ (1) CZ20021551A3 (zh)
EA (1) EA200200545A1 (zh)
HK (1) HK1050132A1 (zh)
HU (1) HUP0204449A3 (zh)
IL (1) IL148579A0 (zh)
MX (1) MXPA02004733A (zh)
NO (1) NO20022245L (zh)
NZ (1) NZ517667A (zh)
PE (1) PE20010701A1 (zh)
PL (1) PL355172A1 (zh)
SK (1) SK6492002A3 (zh)
TR (1) TR200201245T2 (zh)
WO (1) WO2001034137A2 (zh)
ZA (1) ZA200202822B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
KR20030019372A (ko) * 2000-05-09 2003-03-06 크레이톤 유니버시티 암세포의 증식 억제 및 세포사멸 유도 방법
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US7968723B2 (en) 2004-05-05 2011-06-28 High Point Pharmaceuticals, Llc Compounds, their preparation and use
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
EP2298742B1 (en) 2005-06-30 2014-01-08 High Point Pharmaceuticals, LLC phenoxy acetic acids as PPAR delta activators
EP2386540A1 (en) 2005-12-22 2011-11-16 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
JP5207972B2 (ja) 2006-10-12 2013-06-12 株式会社医薬分子設計研究所 カルボン酸誘導体
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
BR112015009751A2 (pt) 2012-10-31 2017-07-11 Bayer Cropscience Ag novos compostos heterocíclicos como pesticidas
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
ZA200202822B (en) 2003-09-23
CZ20021551A3 (cs) 2003-02-12
TR200201245T2 (tr) 2004-08-23
JP2003513916A (ja) 2003-04-15
CN1390139A (zh) 2003-01-08
IL148579A0 (en) 2002-09-12
NO20022245L (no) 2002-07-09
PE20010701A1 (es) 2001-07-07
EA200200545A1 (ru) 2002-12-26
AR032432A1 (es) 2003-11-12
AU778829B2 (en) 2004-12-23
AU1599001A (en) 2001-06-06
WO2001034137A3 (en) 2002-02-14
CA2391416A1 (en) 2001-05-17
HUP0204449A2 (hu) 2003-04-28
MXPA02004733A (es) 2002-08-30
NZ517667A (en) 2004-05-28
PL355172A1 (en) 2004-04-05
BR0015490A (pt) 2002-07-09
WO2001034137A2 (en) 2001-05-17
EP1231938A2 (en) 2002-08-21
NO20022245D0 (no) 2002-05-10
KR20020069512A (ko) 2002-09-04
SK6492002A3 (en) 2003-09-11
HUP0204449A3 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
SI1176964T1 (sl) Uporaba et743 za zdravljenje raka
GB9930570D0 (en) Therapy
GB9907243D0 (en) Therapy
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU8322401A (en) Indole compounds useful for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
GB9901838D0 (en) Slurry treatment
HUP0101947A3 (en) Combination for the treatment of tumors
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
AU1592901A (en) Oncolytic combinations for the treatment of cancer
GB9804361D0 (en) Cancer treatment
AU4598100A (en) Treating cancer
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9911183D0 (en) Treatment of cancers
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
GB9911302D0 (en) Treating cancer